• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
water filter
WATER FILTER FOR WATER PURIFIER
DUST BAG
Small dust filter
HUMIDIFIER FILTER
Oil fume adsorption filter

Lupin launches generic Tobramycin Inhalation Solution USP in US

financialexpressJune 14, 2018

Tag: lupin , generic Tobramycin , USP

Lupin has launched Tobramycin Inhalation Solution USP in the US market. The solution has received an approval from the United States Food and Drug Administration (FDA) earlier.

Lupin’s Tobramycin Inhalation Solution USP, 300 mg/5 ml is the generic equivalent of Novartis Pharmaceuticals Corporation’s Tobi 300 mg/5 ml. It is indicated for the management of cystic fibrosis patients with P. aeruginosa.

Tobramycin Inhalation Solution USP, 300 mg/5 ml had annual sales of approximately USD 99 million in the US (IQVIA MAT April 2018).

Register as Visitor to CPhI China 2018!

Previous:Regenerative bandage accelerates healing in diabetic wounds

Next:Bayer to acquire stake in Monsanto India

Related News

Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases

PharmaSourcesOctober 15, 2024

Thrombolytic Science, LLC (TSI), announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for mutant prourokinase, a recombinant fibrinolytic pro-enzyme.

Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization

PharmaSourcesOctober 15, 2024

BrainDos™ Formulated Dual GIP/GLP-1 Receptor Agonist Tirzepatide Outperforms Tirzepatide Solution (Mounjaro®) in Preclinical Study

PharmaSourcesOctober 15, 2024

Lupin launches generic Tobramycin Inhalation Solution USP in US | Pharmasources.com

BD and ten23 health® Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-Enabled Prefillable Syringes

PharmaSourcesOctober 15, 2024

BD and ten23 health today announced a collaboration to develop a new way to track prefillable syringes (PFS) using RFID technology.

You may like
More>>

Chromium Picolinate USP

Chromium Picolinate USP
Metronidazole   for  suspension 

Metronidazole   for  suspension 
USP/EP/JP cosmetic grade Urea

USP/EP/JP cosmetic grade Urea
100% Natural Polygonum Cuspidatum Root Extract

100% Natural Polygonum Cuspidatum Root Extract
Helicid 98%,USP30 Plant extract Pharmaceutical made in china

Helicid 98%,USP30 Plant extract Pharmaceutical made in china
Polygonum Cuspidatum Extract

Polygonum Cuspidatum Extract
Hydroxypropyl betadex usp inject

Hydroxypropyl betadex usp inject
Folinate Calcium USP28

Folinate Calcium USP28
ChP, USP, EP Amphotericin B 1397-89-3

ChP, USP, EP Amphotericin B 1397-89-3
Zinc Chloride, Granular, USP, JP

Zinc Chloride, Granular, USP, JP

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service